vs
Astrana Health, Inc.（ASTH）とADVANCED DRAINAGE SYSTEMS, INC.（WMS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $693.4M、ADVANCED DRAINAGE SYSTEMS, INC.の約1.4倍）。ADVANCED DRAINAGE SYSTEMS, INC.の純利益率が高く（13.5% vs 0.7%、差は12.8%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 0.4%）。ADVANCED DRAINAGE SYSTEMS, INC.の直近四半期フリーキャッシュフローが多い（$183.6M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 3.0%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
アドバンスド・ドレネージ・システムズ（略称ADS）は米国の企業で、ポリプロピレン・ポリエチレン製パイプ、プラスチック製浸出場システム、浄化槽と付属部品、雨水調整施設、PVC製排水構造物、継手、水ろ過・分離装置の設計・製造・販売を行い、米国最大の高密度ポリエチレンパイプメーカーです。本社はオハイオ州ヒリアードに所在します。
ASTH vs WMS — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $693.4M |
| 純利益 | $6.6M | $93.6M |
| 粗利率 | — | 37.4% |
| 営業利益率 | 1.9% | 19.7% |
| 純利益率 | 0.7% | 13.5% |
| 売上前年比 | 42.9% | 0.4% |
| 純利益前年比 | 184.4% | 15.3% |
| EPS（希薄化後） | $0.12 | $1.19 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $693.4M | ||
| Q3 25 | $956.0M | $850.4M | ||
| Q2 25 | $654.8M | $829.9M | ||
| Q1 25 | $620.4M | $615.8M | ||
| Q4 24 | $665.2M | $690.5M | ||
| Q3 24 | $478.7M | $782.6M | ||
| Q2 24 | $486.3M | $815.3M | ||
| Q1 24 | $404.4M | $653.8M |
| Q4 25 | $6.6M | $93.6M | ||
| Q3 25 | $373.0K | $156.0M | ||
| Q2 25 | $9.4M | $143.9M | ||
| Q1 25 | $6.7M | $77.2M | ||
| Q4 24 | $-7.8M | $81.2M | ||
| Q3 24 | $16.1M | $130.4M | ||
| Q2 24 | $19.2M | $161.4M | ||
| Q1 24 | $14.8M | $94.8M |
| Q4 25 | — | 37.4% | ||
| Q3 25 | — | 40.0% | ||
| Q2 25 | — | 39.8% | ||
| Q1 25 | — | 36.7% | ||
| Q4 24 | — | 35.0% | ||
| Q3 24 | — | 37.6% | ||
| Q2 24 | — | 40.8% | ||
| Q1 24 | — | 38.5% |
| Q4 25 | 1.9% | 19.7% | ||
| Q3 25 | 2.0% | 26.3% | ||
| Q2 25 | 3.1% | 24.8% | ||
| Q1 25 | 3.3% | 19.0% | ||
| Q4 24 | 0.1% | 18.4% | ||
| Q3 24 | 5.9% | 23.9% | ||
| Q2 24 | 6.2% | 27.7% | ||
| Q1 24 | 7.5% | 20.7% |
| Q4 25 | 0.7% | 13.5% | ||
| Q3 25 | 0.0% | 18.3% | ||
| Q2 25 | 1.4% | 17.3% | ||
| Q1 25 | 1.1% | 12.5% | ||
| Q4 24 | -1.2% | 11.8% | ||
| Q3 24 | 3.4% | 16.7% | ||
| Q2 24 | 3.9% | 19.8% | ||
| Q1 24 | 3.7% | 14.5% |
| Q4 25 | $0.12 | $1.19 | ||
| Q3 25 | $0.01 | $1.99 | ||
| Q2 25 | $0.19 | $1.84 | ||
| Q1 25 | $0.14 | $0.99 | ||
| Q4 24 | $-0.14 | $1.04 | ||
| Q3 24 | $0.33 | $1.67 | ||
| Q2 24 | $0.40 | $2.06 | ||
| Q1 24 | $0.31 | $1.22 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $1.0B |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $779.3M | $1.9B |
| 総資産 | $2.2B | $4.1B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $1.0B | ||
| Q3 25 | $463.4M | $812.9M | ||
| Q2 25 | $342.1M | $638.3M | ||
| Q1 25 | $260.9M | $463.3M | ||
| Q4 24 | $290.8M | $488.9M | ||
| Q3 24 | $350.3M | $613.0M | ||
| Q2 24 | $327.7M | $541.6M | ||
| Q1 24 | $337.3M | $490.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $1.3B |
| Q4 25 | $779.3M | $1.9B | ||
| Q3 25 | $775.5M | $1.8B | ||
| Q2 25 | $765.5M | $1.7B | ||
| Q1 25 | $745.4M | $1.5B | ||
| Q4 24 | $712.7M | $1.5B | ||
| Q3 24 | $704.6M | $1.4B | ||
| Q2 24 | $678.9M | $1.3B | ||
| Q1 24 | $653.5M | $1.2B |
| Q4 25 | $2.2B | $4.1B | ||
| Q3 25 | $2.2B | $4.1B | ||
| Q2 25 | $1.4B | $3.9B | ||
| Q1 25 | $1.3B | $3.7B | ||
| Q4 24 | $1.4B | $3.6B | ||
| Q3 24 | $1.3B | $3.5B | ||
| Q2 24 | $1.3B | $3.4B | ||
| Q1 24 | $1.2B | $3.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.83× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.11× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $269.3M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $183.6M |
| FCFマージンFCF / 売上 | -0.6% | 26.5% |
| 設備投資強度設備投資 / 売上 | 0.3% | 12.4% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 2.88× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $577.1M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $269.3M | ||
| Q3 25 | $10.0M | $234.9M | ||
| Q2 25 | $90.9M | $275.0M | ||
| Q1 25 | $16.6M | $41.2M | ||
| Q4 24 | $-10.9M | $189.9M | ||
| Q3 24 | $34.0M | $166.9M | ||
| Q2 24 | $23.2M | $183.4M | ||
| Q1 24 | $6.0M | $17.7M |
| Q4 25 | $-6.0M | $183.6M | ||
| Q3 25 | $7.4M | $176.4M | ||
| Q2 25 | $89.5M | $222.4M | ||
| Q1 25 | $13.6M | $-5.3M | ||
| Q4 24 | $-13.5M | $135.7M | ||
| Q3 24 | $31.7M | $112.4M | ||
| Q2 24 | $20.4M | $125.7M | ||
| Q1 24 | $5.6M | $-29.8M |
| Q4 25 | -0.6% | 26.5% | ||
| Q3 25 | 0.8% | 20.7% | ||
| Q2 25 | 13.7% | 26.8% | ||
| Q1 25 | 2.2% | -0.9% | ||
| Q4 24 | -2.0% | 19.7% | ||
| Q3 24 | 6.6% | 14.4% | ||
| Q2 24 | 4.2% | 15.4% | ||
| Q1 24 | 1.4% | -4.6% |
| Q4 25 | 0.3% | 12.4% | ||
| Q3 25 | 0.3% | 6.9% | ||
| Q2 25 | 0.2% | 6.3% | ||
| Q1 25 | 0.5% | 7.6% | ||
| Q4 24 | 0.4% | 7.9% | ||
| Q3 24 | 0.5% | 7.0% | ||
| Q2 24 | 0.6% | 7.1% | ||
| Q1 24 | 0.1% | 7.3% |
| Q4 25 | -0.44× | 2.88× | ||
| Q3 25 | 26.69× | 1.51× | ||
| Q2 25 | 9.65× | 1.91× | ||
| Q1 25 | 2.48× | 0.53× | ||
| Q4 24 | — | 2.34× | ||
| Q3 24 | 2.11× | 1.28× | ||
| Q2 24 | 1.21× | 1.14× | ||
| Q1 24 | 0.40× | 0.19× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
WMS
| Reportable Segment Aggregation Before Other Operating Segment | $557.3M | 80% |
| Other | $85.5M | 12% |
| Pipe | $35.5M | 5% |
| Allied Products And Other | $15.0M | 2% |
